138 related articles for article (PubMed ID: 25325219)
21. The effects of cardiac rehabilitation on haemodynamic parameters measured by impedance cardiography in patients with heart failure.
Gielerak G; Piotrowicz E; Krzesiński P; Kowal J; Grzęda M; Piotrowicz R
Kardiol Pol; 2011; 69(4):309-17. PubMed ID: 21523660
[TBL] [Abstract][Full Text] [Related]
22. In chronic heart failure with marked fluid retention, the i.v. high doses of loop diuretic are a predictor of aggravated renal dysfunction, especially in the set of heart failure with normal or only mildly impaired left ventricular systolic function.
De Vecchis R; Ciccarelli A; Ariano C; Cioppa C; Giasi A; Pucciarelli A; Cantatrione S
Minerva Cardioangiol; 2011 Dec; 59(6):543-54. PubMed ID: 21330961
[TBL] [Abstract][Full Text] [Related]
23. Effect of severe left ventricular systolic dysfunction on hospital outcome after transcatheter aortic valve implantation or surgical aortic valve replacement: results from a propensity-matched population of the Italian OBSERVANT multicenter study.
Onorati F; D'Errigo P; Grossi C; Barbanti M; Ranucci M; Covello DR; Rosato S; Maraschini A; Santoro G; Tamburino C; Seccareccia F; Santini F; Menicanti L;
J Thorac Cardiovasc Surg; 2014 Feb; 147(2):568-75. PubMed ID: 24263007
[TBL] [Abstract][Full Text] [Related]
24. [Role of controlled physical activity as a method of therapy in patients with heart failure after invasive treatment of angina pectoris].
Irzmański R; Kapusta J; Kowalski J
Pol Merkur Lekarski; 2014 Aug; 37(218):77-81. PubMed ID: 25252439
[TBL] [Abstract][Full Text] [Related]
25. Different characteristics of chronic heart failure (CHF) in elderly diabetics and non-diabetics.
Romeo R; Scalisi C; Tafuri L; Romeo A; Maugeri D; Sorace R
Arch Gerontol Geriatr; 2010; 50(1):101-4. PubMed ID: 19371958
[TBL] [Abstract][Full Text] [Related]
26. Changes in ventricular remodelling and clinical status during the year following a single administration of stromal cell-derived factor-1 non-viral gene therapy in chronic ischaemic heart failure patients: the STOP-HF randomized Phase II trial.
Chung ES; Miller L; Patel AN; Anderson RD; Mendelsohn FO; Traverse J; Silver KH; Shin J; Ewald G; Farr MJ; Anwaruddin S; Plat F; Fisher SJ; AuWerter AT; Pastore JM; Aras R; Penn MS
Eur Heart J; 2015 Sep; 36(33):2228-38. PubMed ID: 26056125
[TBL] [Abstract][Full Text] [Related]
27. Reduction of N terminal-pro-brain (B-type) natriuretic peptide levels with exercise-based cardiac rehabilitation in patients with left ventricular dysfunction after myocardial infarction.
Giallauria F; De Lorenzo A; Pilerci F; Manakos A; Lucci R; Psaroudaki M; D'Agostino M; Del Forno D; Vigorito C
Eur J Cardiovasc Prev Rehabil; 2006 Aug; 13(4):625-32. PubMed ID: 16874155
[TBL] [Abstract][Full Text] [Related]
28. Value of brain natriuretic peptide after acute myocardial infarction.
Güneş Y; Okçün B; Kavlak E; Erbaş C; Karcier S
Anadolu Kardiyol Derg; 2008 Jun; 8(3):182-7. PubMed ID: 18524723
[TBL] [Abstract][Full Text] [Related]
29. Sex Differences in Left Ventricular Cavity Dilation and Outcomes in Acute Heart Failure Patients With Left Ventricular Systolic Dysfunction.
Kajimoto K; Minami Y; Otsubo S; Sato N;
Can J Cardiol; 2018 Apr; 34(4):477-484. PubMed ID: 29571428
[TBL] [Abstract][Full Text] [Related]
30. B-type natriuretic peptide and echocardiographic determination of ejection fraction in the diagnosis of congestive heart failure in patients with acute dyspnea.
Steg PG; Joubin L; McCord J; Abraham WT; Hollander JE; Omland T; Mentré F; McCullough PA; Maisel AS
Chest; 2005 Jul; 128(1):21-9. PubMed ID: 16002911
[TBL] [Abstract][Full Text] [Related]
31. N-terminal probrain natriuretic peptide predicts adverse outcomes in acute-myocardial infarction even with preserved left ventricular ejection fraction.
Puri A; Narain VS; Mehrotra S; Dwivedi SK; Saran RK; Puri VK
Indian Heart J; 2006; 58(2):138-43. PubMed ID: 18989058
[TBL] [Abstract][Full Text] [Related]
32. Contemporary trends in cardiac rehabilitation in Germany: patient characteristics, drug treatment, and risk-factor management from 2000 to 2005.
Bestehorn K; Wegscheider K; Völler H
Eur J Cardiovasc Prev Rehabil; 2008 Jun; 15(3):312-8. PubMed ID: 18525386
[TBL] [Abstract][Full Text] [Related]
33. Heart failure with preserved vs reduced ejection fraction following cardiac rehabilitation: impact of endothelial function.
Tanaka S; Sanuki Y; Ozumi K; Harada T; Tasaki H
Heart Vessels; 2018 Aug; 33(8):886-892. PubMed ID: 29392470
[TBL] [Abstract][Full Text] [Related]
34. Natural history of asymptomatic left ventricular systolic dysfunction in the community.
Wang TJ; Evans JC; Benjamin EJ; Levy D; LeRoy EC; Vasan RS
Circulation; 2003 Aug; 108(8):977-82. PubMed ID: 12912813
[TBL] [Abstract][Full Text] [Related]
35. Growth differentiation factor 15 in heart failure with preserved vs. reduced ejection fraction.
Chan MM; Santhanakrishnan R; Chong JP; Chen Z; Tai BC; Liew OW; Ng TP; Ling LH; Sim D; Leong KT; Yeo PS; Ong HY; Jaufeerally F; Wong RC; Chai P; Low AF; Richards AM; Lam CS
Eur J Heart Fail; 2016 Jan; 18(1):81-8. PubMed ID: 26497848
[TBL] [Abstract][Full Text] [Related]
36. B-type natriuretic peptide and prognosis in heart failure patients with preserved and reduced ejection fraction.
van Veldhuisen DJ; Linssen GC; Jaarsma T; van Gilst WH; Hoes AW; Tijssen JG; Paulus WJ; Voors AA; Hillege HL
J Am Coll Cardiol; 2013 Apr; 61(14):1498-506. PubMed ID: 23500300
[TBL] [Abstract][Full Text] [Related]
37. Diagnostic and prognostic significance of plasma N-terminal-pro-brain natriuretic peptide in decompensated heart failure with preserved ejection fraction.
Paul B; Soon KH; Dunne J; De Pasquale CG
Heart Lung Circ; 2008 Dec; 17(6):497-501. PubMed ID: 18722158
[TBL] [Abstract][Full Text] [Related]
38. Heart failure with normal ejection fraction is uncommon in acute myocardial infarction settings but associated with poor outcomes: a study of 91,360 patients admitted with index myocardial infarction between 1998 and 2010.
Desta L; Jernberg T; Spaak J; Hofman-Bang C; Persson H
Eur J Heart Fail; 2016 Jan; 18(1):46-53. PubMed ID: 26503670
[TBL] [Abstract][Full Text] [Related]
39. Outcomes After Implantable Cardioverter-Defibrillator Generator Replacement for Primary Prevention of Sudden Cardiac Death.
Madhavan M; Waks JW; Friedman PA; Kramer DB; Buxton AE; Noseworthy PA; Mehta RA; Hodge DO; Higgins AY; Webster TL; Witt CM; Cha YM; Gersh BJ
Circ Arrhythm Electrophysiol; 2016 Mar; 9(3):e003283. PubMed ID: 26921377
[TBL] [Abstract][Full Text] [Related]
40. Effect of Carvedilol on Serum Heart-type Fatty Acid-binding Protein, Brain Natriuretic Peptide, and Cardiac Function in Patients With Chronic Heart Failure.
Sun YP; Wei CP; Ma SC; Zhang YF; Qiao LY; Li DH; Shan RB
J Cardiovasc Pharmacol; 2015 May; 65(5):480-4. PubMed ID: 25945865
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
